Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: 8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.; No adverse event; 8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.), PRODUCT STORAGE ERROR (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Dec-2022, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Oct-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.), PRODUCT STORAGE ERROR (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.) and PRODUCT STORAGE ERROR (8 patients received Moderna COVID-19 primary doses from Lot 037C21A and MFG Expiration Date 02 Jan 2022. The vials were thawed and administered on 23OCT2022.).    The 100 doses of monovalent vaccine was already discarded but the state said that they could had used it, after beyond use date.  The vials were thawed and administered on 23OCT2022. The remainder of vials were discarded already. He states that they received the vaccine as frozen from the state and placed it in the freezer.  There had never been a temperature excursion.  Patient states that do not know what the state means by saying that we could had used the vaccine after beyond use date. No treatment information was provided by the reporter. This is 7th patient out of 8 patient.   This case was linked to US-MODERNATX, INC.-MOD-2023-694237 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-694237:master case